Cyclerion Therapeutics, Inc. (CYCN) — SC 13G/A Filings
All SC 13G/A filings from Cyclerion Therapeutics, Inc.. Browse 5 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (5)
- SC 13G/A Filing — Jul 12, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Artal International Updates Cyclerion Therapeutics Stake
— Feb 9, 2024 Risk: low
Artal International S.C.A. and its affiliated entities, including Invus Public Equities, L.P., filed an amended Schedule 13G/A on February 9, 2024, disclosing t -
FMR LLC & Abigail Johnson Hold 6.66% Stake in Cyclerion Therapeutics
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Cyclerion Therapeutics, Inc. This SC 13G/A -
Slate Path Capital LP Holds 357,880 Shares of Cyclerion Therapeutics
— Jan 22, 2024
Slate Path Capital LP, a Delaware-based investment firm, filed an amended SC 13G/A on January 22, 2024, disclosing its beneficial ownership in Cyclerion Therape
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX